BAKER SHENDA has a total of 14 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and environmental technology are 3D MATRIX INC, STEM CELLS SPIN S A and ELLIES DEBRA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Organic fine chemistry | |
#6 | Measurement | |
#7 | Biotechnology | |
#8 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Baker Shenda | 14 |
#2 | Wiesmann William P | 14 |
#3 | Townsend Stacy | 3 |
#4 | Ryan Shannon | 3 |
#5 | Baxter Ruth | 3 |
#6 | Townsend Stacy M | 2 |
#7 | Rogelj Snezna | 2 |
#8 | Orwin Elizabeth | 1 |
Publication | Filing date | Title |
---|---|---|
US2014221308A1 | Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds | |
WO2008063503A2 | Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials. | |
US2008248508A1 | Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials |